Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a revision update from v3.4.1 to v3.4.2; no changes to study content or core functionality are evident.SummaryDifference0.1%

- Check20 days agoChange DetectedA minor site version update from v3.4.0 to v3.4.1 is applied with no observed user-facing changes to the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary control added and page revision updated to v3.4.0. Metadata labels were adjusted, including Last Update Submitted that Met QC Criteria and No FEAR Act data.SummaryDifference0.2%

- Check42 days agoChange DetectedSite revision label updated from v3.3.3 to v3.3.4; this minor change does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; no visible changes to study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.